(11-419) Evaluation of Inclusion of Droxidopa as a Therapeutic Option for Intravenous Vasopressor Weaning on Intensive Care Unit Length of Stay in Patients with Distributive Shock
Wednesday, December 10, 2025
12:30 PM - 1:30 PM
Location: Bayside A, Level 1
Residency Program: Plainview Hospital Residency Program Type: PGY1 (Pharmacy) Residency Program Location: New York
